The report noted a strong quarterly dividend history at AbbVie Inc, and favorable long-term multi-year growth rates in key fundamental data points. The annualized dividend paid by AbbVie Inc is $6 ...

AbbVie Inc (Symbol: ABBV) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.2% yield, as well as a ...

Even more alarming is AbbVie's payout ratio of 216.7%, far surpassing the peer average of 141%. This sky-high figure means ...

Investing in “dividend powerhouses” — companies with stellar dividend payments and growth histories — is a smart way to ...

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

This announcement marks another step in AbbVie's history of providing dividends to its shareholders. Since its formation in 2013, the pharmaceutical company has increased its dividend payout by more ...

Historically, September is a relatively bad month for stock markets. AT&T offers a huge dividend yield and it could start raising the payout again next year. AbbVie is a leading pharmaceutical ...

Shares of AbbVie Inc. ABBV inched 0.35% higher to $193.62 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

DBS analyst Mark Kong CFA has maintained their neutral stance on ABBV stock, giving a Hold rating on September 3. Mark Kong CFA has given his ...

AbbVie has raised its quarterly payment every year since spinning off from Abbott Laboratories in 2013 and its parent's dividend-raising history goes back even further. Abbott has raised its ...